JP2013524213A5 - - Google Patents

Download PDF

Info

Publication number
JP2013524213A5
JP2013524213A5 JP2013502539A JP2013502539A JP2013524213A5 JP 2013524213 A5 JP2013524213 A5 JP 2013524213A5 JP 2013502539 A JP2013502539 A JP 2013502539A JP 2013502539 A JP2013502539 A JP 2013502539A JP 2013524213 A5 JP2013524213 A5 JP 2013524213A5
Authority
JP
Japan
Prior art keywords
sample
complement activation
human
assay
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013502539A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013524213A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2011/050369 external-priority patent/WO2011123044A1/en
Publication of JP2013524213A publication Critical patent/JP2013524213A/ja
Publication of JP2013524213A5 publication Critical patent/JP2013524213A5/ja
Pending legal-status Critical Current

Links

JP2013502539A 2010-03-31 2011-03-30 炎症をもたらす組織分解を検出する方法 Pending JP2013524213A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1050310 2010-03-31
SE1050310-0 2010-03-31
PCT/SE2011/050369 WO2011123044A1 (en) 2010-03-31 2011-03-30 Method to detect tissue degradation leading to inflammation

Publications (2)

Publication Number Publication Date
JP2013524213A JP2013524213A (ja) 2013-06-17
JP2013524213A5 true JP2013524213A5 (https=) 2014-05-08

Family

ID=44712493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013502539A Pending JP2013524213A (ja) 2010-03-31 2011-03-30 炎症をもたらす組織分解を検出する方法

Country Status (5)

Country Link
US (1) US20130084584A1 (https=)
EP (1) EP2553465A4 (https=)
JP (1) JP2013524213A (https=)
AU (1) AU2011233753A1 (https=)
WO (1) WO2011123044A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3771468A1 (en) * 2019-07-31 2021-02-03 Universitätsklinikum Hamburg-Eppendorf C3/c5 convertase assays

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4642284A (en) * 1983-06-13 1987-02-10 Scripps Clinic And Research Foundation Method and system for detection of complement pathway activation
SE452065B (sv) * 1986-04-11 1987-11-09 Ulf R Nilsson Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning
IL84160A0 (en) * 1986-10-16 1988-03-31 Vasocor Method and kit for immune complex assay
KR20000064637A (ko) * 1996-03-19 2000-11-06 에프.지.엠. 헤르만스 비(b)형 간염의 감염 결과를 예측하는 방법
SE9904236D0 (sv) * 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
CA2502926A1 (en) * 2002-11-08 2004-05-27 Linda J. Sandell Uncoupled collagen synthesis and degradation assays
ES2360804T3 (es) * 2004-05-24 2011-06-09 Anamar Ab Método para determinar un proceso de degradación tisular mediante la detección de neoepítopos de comp.
BRPI0812767A2 (pt) * 2007-06-07 2014-12-02 Genentech Inc Anticorpos para c3b e métodos para prevenção e tratamento de distúrbios associados ao complemento
CA2690568A1 (en) * 2007-06-20 2008-12-24 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
EP3112379A1 (en) * 2008-03-21 2017-01-04 Universiteit Hasselt Biomarkers for rheumatoid arthritis

Similar Documents

Publication Publication Date Title
Vashist et al. One-step kinetics-based immunoassay for the highly sensitive detection of C-reactive protein in less than 30 min
Wang et al. Competitive immunoassays for the detection of small molecules using single molecule arrays
Lee et al. Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC)
Sener et al. Rapid real-time detection of procalcitonin using a microcontact imprinted surface plasmon resonance biosensor
JP2019530875A5 (https=)
Mezzano et al. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays
JP2019516966A5 (https=)
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
Lehner et al. Methodological and preanalytical evaluation of an HMGB1 immunoassay
JP2012509477A5 (https=)
WO2008063663A3 (en) Poly (ethylene glycol) anti-body detection assays and kits for performing thereof
JP2012073260A5 (https=)
JP2015230280A5 (https=)
Shah et al. Calibration-free concentration analysis of protein biomarkers in human serum using surface plasmon resonance
Liu et al. Preparation of a peptide-modified electrode for capture and voltammetric determination of endotoxin
RU2012148244A (ru) Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
Madhurantakam et al. Multiplex sensing of IL-10 and CRP towards predicting critical illness in COVID-19 infections
JP2015505371A5 (https=)
JP2016511407A5 (https=)
Chon et al. SERS-based immunoassay of anti-cyclic citrullinated peptide for early diagnosis of rheumatoid arthritis
Wu et al. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology
Zhang et al. Detection of TNF-α using the established ab-MPs-CLIA
Hardy et al. Is lupus anticoagulant testing with dilute Russell’s viper venom clotting times reliable in the presence of inflammation?
Safi Hepatitis C: an Overview of Various Laboratory Assays with their Mode of Diagnostic Cooperation.
Kuno et al. LecT-Hepa: A triplex lectin–antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine